WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Website Development Friday, June 12, 2026 
Add Press Release News | News Feeds Feeds | Email This News Email


LifeScience Technologies, LLC Files Lawsuit Against St. Louis-Based Mercy Health and Mercy Virtual, and San Francisco-Based Myia Health
Tuesday, November 9, 2021

LifeScience Technologies (LST), developer of m.Care®, one of the leading telehealth and remote patient engagement platforms in the U.S., announced today it filed a lawsuit against St. Louis-based Mercy Health (http://www.mercy.net), Mercy Virtual (http://www.mercyvirtual.net), and San Francisco-based Myia Health (http://www.myiahealth.com).

LEAWOOD, Kan., Nov. 1, 2021 /PRNewswire-PRWeb/ -- LifeScience Technologies (LST), developer of m.Care®, one of the leading telehealth and remote patient engagement platforms in the U.S., announced today it filed a lawsuit against St. Louis-based Mercy Health (http://www.mercy.net), Mercy Virtual (http://www.mercyvirtual.net), and San Francisco-based Myia Health (http://www.myiahealth.com).

The case number is: 4:21-CV-01279-SEP. The case is LifeScience Technologies, LLC v. Mercy Health, et al.¸ and is currently pending in the United States District Court for the Eastern District of Missouri, Eastern Division.

Details of the Claim

As alleged in the complaint, the lawsuit details breach of contract, trade secret misappropriation, unjust enrichment, unfair competition, civil conspiracy, and willful and deliberate disclosure of LST's trade secrets and confidential information by Mercy Health and Mercy Virtual to a third-party competitor, Myia Health, for purposes of developing a competing virtual care software platform.

Comment From LifeScience Technologies

"As adoption of the m.Care® platform continues to grow at an accelerated rate within healthcare and related markets, we are disappointed we have to use the legal system to protect our existing contracts, non-disclosure agreements, and intellectual property rights, especially with a client with whom we have worked closely for more than seven years," said LifeScience Technologies President Steve Hendrix.

"Having worked in the healthcare technology space for over 30 years, our management team is proud of both the solutions we have created to help care teams and patients, and the high level of integrity that has defined our companies. This is the first time, in those 30 years, that we have needed to enforce our contracts and protected work product via a lawsuit. We will, however, always protect our company and our clients against willful and damaging misconduct," Hendrix continued.

"Our software and processes are, and remain, highly secure," Hendrix stated. "One of the reasons for our strong security, as evidenced by our recently completed SOC 2 Type 2 + HIPAA assessment, is the solid, non-disclosure agreement and software license agreements in place with each of our clients. If a contract breach occurs, we have a responsibility, and indeed a requirement, to pursue an injunction and relief."

m.Care®

m.Care® powers numerous visionary, forward-thinking hospitals, healthcare systems and other organizations focused on patient, member, or employee health and well-being.

The need existed to create an innovative, leading-edge technology that was very advanced 'under the covers,' but very simple and intuitive for care teams and patients to use. m.Care® provides a highly configurable and easy-to-use platform to meet its clients' specific needs and clinical protocols, enabling predictive and proactive care. Highlighted outcomes from our clients:

    --  Patient satisfaction rate is very high, over 98%
    --  Documented cost savings for the challenging critical care at-home
        populations, over 32%
    --  Reductions in readmissions, over 50%

Summary

The lawsuit claims that Mercy gave Myia access to gain knowledge and know-how regarding LST's m.Care® software, acquired a $5 Million ownership interest in Myia, then replaced LST's Software with Myia's derivative software in the Mercy vEngagement program.

Media Contact: Adam Taff, 913.484.1140. adamt@karunaconsulting.com

Media Contact

Steve Hendrix, m.Care, +1 9132696452, steveh@m.care

Tom McCarthy, LifeScience Technologoes, 9134858764, tmccarthy@lifesciencetechnologies.com

SOURCE LifeScience Technologies



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Asetek - Mandatory Notification of Trade | Jan 22, 2026
Nav BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
Nav Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
Nav Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
Nav Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
Nav California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
Nav AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
Nav Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
Nav Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
Nav Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News